Objective: This paper aimed to investigate the PI3K/Akt/mTOR signal-pathway regulator factor-related lncRNAsignatures (PAM-SRFLncSigs). associated with regulators of the indicated signaling pathway in patients with lungadenocarcinoma (LUAD) undergoing immunotherapy. Materials and Methods: In this retrospective study. we employed univariate Cox. https://parisnaturalfoodes.shop/product-category/zinc-chelate-25-mg/